Gilead says it can produce ‘several million’ rounds of remdesivir coronavirus treatments next year

[ad_1]

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues.

Ulrich Perrey | Reuters

Gilead Sciences said Thursday that it can produce “several million” rounds of its antiviral drug remdesivir to help patients fight the coronavirus.

This is a developing story. Please check back for updates.

[ad_2]

Source link